0001567619-18-002130.txt : 20180905 0001567619-18-002130.hdr.sgml : 20180905 20180905152342 ACCESSION NUMBER: 0001567619-18-002130 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180905 DATE AS OF CHANGE: 20180905 EFFECTIVENESS DATE: 20180905 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALZHEON, INC. CENTRAL INDEX KEY: 0001582636 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463074149 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-288477 FILM NUMBER: 181054988 BUSINESS ADDRESS: STREET 1: 111 SPEEN STREET STREET 2: SUITE 306 CITY: FRAMINGHAM STATE: MA ZIP: 01701 BUSINESS PHONE: 857-214-7242 MAIL ADDRESS: STREET 1: 111 SPEEN STREET STREET 2: SUITE 306 CITY: FRAMINGHAM STATE: MA ZIP: 01701 D/A 1 primary_doc.xml X0708 D/A LIVE 0001582636 ALZHEON, INC. 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 508-861-7709 DELAWARE None None Corporation true 2013 David Nikodem 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Scott Minick 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Martin Tolar 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Executive Officer Director Franz Hefti 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Dennis Langer 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Jean-Pierre Garnier 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Kenneth A. Mace 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Executive Officer Neil W. Flanzraich 111 Speen Street Framingham MA MASSACHUSETTS 01701 Director Biotechnology Decline to Disclose 06b true 0001140361-17-024576 2017-05-25 true true false 0 CIM Securities, LLC None None 120852 509 Madison Avenue Suite 906 New York NY NEW YORK 10022 CA CALIFORNIA CO COLORADO DE DELAWARE FL FLORIDA IL ILLINOIS MA MASSACHUSETTS MD MARYLAND NJ NEW JERSEY NY NEW YORK TX TEXAS WY WYOMING false 19801820 19801820 0 Total Offering Amount and Total Amount Sold also include the conversion of Promissory Notes. false 81 189955 0 0 false ALZHEON, INC. /s/ Martin Tolar Martin Tolar Chief Executive Officer 2018-09-05